(Q33329945)

English

A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

Adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Groves MD

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Maor MH

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Meyers C

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Kyritsis AP

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jaeckle KA

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Yung WK

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sawaya RE

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Hess K

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bruner JM

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Peterson P

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Levin VA

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

127-135

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Review: total doses in fractionated radiotherapy--implications of new radiobiological data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of bromodeoxyuridine in glioblastoma multiforme: A A Northern California cancer center phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal Aberrations in Synchronized Mammalian Cells treated with 5-Bromodeoxyuridine and irradiated by Ultra-violet Light

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the chemical basis of cellular radiosensitization by 5-bromouracil substitution in DNA. II. Pulse- and steadystate radiolysis of bromouracil-substituted and unsubstituted DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitizing nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of Chinese hamster V79 cells by bromodeoxyuridine substitution of thymidine: enhancement of radiation-induced toxicity and DNA strand break production by monofilar and bifilar substitution.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of radiosensitization by halogenated pyrimidines: bromodeoxyuridine and beta-arabinofuranosyladenine affect similar subsets of radiation-induced potentially lethal lesions in plateau-phase Chinese hamster ovary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of Radiation-Induced Mitotic Inhibition by BUdR Incorporation in L-Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective reminding test: an examination of the equivalence of four forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Robust Locally Weighted Regression and Smoothing Scatterplots

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The exact analysis of contingency tables in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastom

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Resection and reoperation in neuro-oncology. Rationale and approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for neoplasms of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900122-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00122-4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33329945&oldid=1611990716"